RESMED INC (RMD) Fundamental Analysis & Valuation

NYSE:RMD • US7611521078

Current stock price

230.52 USD
-0.32 (-0.14%)
Last:

This RMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. RMD Profitability Analysis

1.1 Basic Checks

  • In the past year RMD was profitable.
  • In the past year RMD had a positive cash flow from operations.
  • Each year in the past 5 years RMD has been profitable.
  • In the past 5 years RMD always reported a positive cash flow from operatings.
RMD Yearly Net Income VS EBIT VS OCF VS FCFRMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • RMD has a better Return On Assets (17.47%) than 97.28% of its industry peers.
  • Looking at the Return On Equity, with a value of 23.51%, RMD belongs to the top of the industry, outperforming 96.20% of the companies in the same industry.
  • RMD has a Return On Invested Capital of 20.84%. This is amongst the best in the industry. RMD outperforms 97.83% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for RMD is significantly above the industry average of 9.18%.
  • The 3 year average ROIC (18.06%) for RMD is below the current ROIC(20.84%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 17.47%
ROE 23.51%
ROIC 20.84%
ROA(3y)15.1%
ROA(5y)14.12%
ROE(3y)22.06%
ROE(5y)21.17%
ROIC(3y)18.06%
ROIC(5y)18.51%
RMD Yearly ROA, ROE, ROICRMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • RMD has a Profit Margin of 27.53%. This is amongst the best in the industry. RMD outperforms 97.28% of its industry peers.
  • In the last couple of years the Profit Margin of RMD has grown nicely.
  • RMD's Operating Margin of 34.11% is amongst the best of the industry. RMD outperforms 99.46% of its industry peers.
  • In the last couple of years the Operating Margin of RMD has grown nicely.
  • RMD's Gross Margin of 60.85% is fine compared to the rest of the industry. RMD outperforms 62.50% of its industry peers.
  • In the last couple of years the Gross Margin of RMD has remained more or less at the same level.
Industry RankSector Rank
OM 34.11%
PM (TTM) 27.53%
GM 60.85%
OM growth 3Y5.43%
OM growth 5Y3.67%
PM growth 3Y7.71%
PM growth 5Y5.3%
GM growth 3Y1.6%
GM growth 5Y0.42%
RMD Yearly Profit, Operating, Gross MarginsRMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

8

2. RMD Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), RMD is creating value.
  • RMD has less shares outstanding than it did 1 year ago.
  • RMD has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for RMD has been reduced compared to a year ago.
RMD Yearly Shares OutstandingRMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
RMD Yearly Total Debt VS Total AssetsRMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • RMD has an Altman-Z score of 12.05. This indicates that RMD is financially healthy and has little risk of bankruptcy at the moment.
  • RMD has a Altman-Z score of 12.05. This is amongst the best in the industry. RMD outperforms 93.48% of its industry peers.
  • RMD has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 0.37, RMD belongs to the best of the industry, outperforming 91.30% of the companies in the same industry.
  • RMD has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.06, RMD is doing good in the industry, outperforming 67.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.37
Altman-Z 12.05
ROIC/WACC2.08
WACC10.01%
RMD Yearly LT Debt VS Equity VS FCFRMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • RMD has a Current Ratio of 3.06. This indicates that RMD is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 3.06, RMD perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
  • RMD has a Quick Ratio of 2.32. This indicates that RMD is financially healthy and has no problem in meeting its short term obligations.
  • RMD has a Quick ratio of 2.32. This is comparable to the rest of the industry: RMD outperforms 58.15% of its industry peers.
Industry RankSector Rank
Current Ratio 3.06
Quick Ratio 2.32
RMD Yearly Current Assets VS Current LiabilitesRMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

6

3. RMD Growth Analysis

3.1 Past

  • RMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.29%, which is quite good.
  • The Earnings Per Share has been growing by 14.94% on average over the past years. This is quite good.
  • RMD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.57%.
  • The Revenue has been growing by 11.72% on average over the past years. This is quite good.
EPS 1Y (TTM)16.29%
EPS 3Y18.15%
EPS 5Y14.94%
EPS Q2Q%15.64%
Revenue 1Y (TTM)9.57%
Revenue growth 3Y12.88%
Revenue growth 5Y11.72%
Sales Q2Q%10.98%

3.2 Future

  • Based on estimates for the next years, RMD will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.77% on average per year.
  • RMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.40% yearly.
EPS Next Y16.4%
EPS Next 2Y13.39%
EPS Next 3Y11.65%
EPS Next 5Y10.77%
Revenue Next Year10.03%
Revenue Next 2Y8.69%
Revenue Next 3Y7.93%
Revenue Next 5Y8.4%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
RMD Yearly Revenue VS EstimatesRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
RMD Yearly EPS VS EstimatesRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

6

4. RMD Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 22.42 indicates a rather expensive valuation of RMD.
  • Compared to the rest of the industry, the Price/Earnings ratio of RMD indicates a somewhat cheap valuation: RMD is cheaper than 76.63% of the companies listed in the same industry.
  • RMD is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 18.77, RMD is valued on the expensive side.
  • RMD's Price/Forward Earnings ratio is rather cheap when compared to the industry. RMD is cheaper than 80.98% of the companies in the same industry.
  • RMD is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.42
Fwd PE 18.77
RMD Price Earnings VS Forward Price EarningsRMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • RMD's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. RMD is cheaper than 76.63% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of RMD indicates a rather cheap valuation: RMD is cheaper than 90.22% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.9
EV/EBITDA 16.07
RMD Per share dataRMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • RMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.37
PEG (5Y)1.5
EPS Next 2Y13.39%
EPS Next 3Y11.65%

7

5. RMD Dividend Analysis

5.1 Amount

  • RMD has a Yearly Dividend Yield of 1.03%. Purely for dividend investing, there may be better candidates out there.
  • RMD's Dividend Yield is rather good when compared to the industry average which is at 0.22. RMD pays more dividend than 92.39% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, RMD's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.03%

5.2 History

  • On average, the dividend of RMD grows each year by 6.33%, which is quite nice.
  • RMD has been paying a dividend for at least 10 years, so it has a reliable track record.
  • RMD has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.33%
Div Incr Years12
Div Non Decr Years12
RMD Yearly Dividends per shareRMD Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 22.25% of the earnings are spent on dividend by RMD. This is a low number and sustainable payout ratio.
  • RMD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP22.25%
EPS Next 2Y13.39%
EPS Next 3Y11.65%
RMD Yearly Income VS Free CF VS DividendRMD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
RMD Dividend Payout.RMD Dividend Payout, showing the Payout Ratio.RMD Dividend Payout.PayoutRetained Earnings

RMD Fundamentals: All Metrics, Ratios and Statistics

RESMED INC

NYSE:RMD (3/16/2026, 12:43:59 PM)

230.52

-0.32 (-0.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-29
Earnings (Next)04-21
Inst Owners68.21%
Inst Owner Change5.84%
Ins Owners0.49%
Ins Owner Change-0.27%
Market Cap33.58B
Revenue(TTM)5.40B
Net Income(TTM)1.49B
Analysts74.4
Price Target303.44 (31.63%)
Short Float %8.17%
Short Ratio10.81
Dividend
Industry RankSector Rank
Dividend Yield 1.03%
Yearly Dividend2.12
Dividend Growth(5Y)6.33%
DP22.25%
Div Incr Years12
Div Non Decr Years12
Ex-Date02-12
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.49%
Min EPS beat(2)-1.16%
Max EPS beat(2)2.15%
EPS beat(4)2
Avg EPS beat(4)0.54%
Min EPS beat(4)-1.16%
Max EPS beat(4)2.15%
EPS beat(8)5
Avg EPS beat(8)2.85%
EPS beat(12)8
Avg EPS beat(12)2.12%
EPS beat(16)10
Avg EPS beat(16)1.2%
Revenue beat(2)1
Avg Revenue beat(2)0.14%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)0.91%
Revenue beat(4)2
Avg Revenue beat(4)0.12%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)0.91%
Revenue beat(8)5
Avg Revenue beat(8)0.55%
Revenue beat(12)7
Avg Revenue beat(12)0.61%
Revenue beat(16)8
Avg Revenue beat(16)0.24%
PT rev (1m)-0.03%
PT rev (3m)1.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.22%
EPS NY rev (1m)0%
EPS NY rev (3m)1.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.98%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.73%
Valuation
Industry RankSector Rank
PE 22.42
Fwd PE 18.77
P/S 6.22
P/FCF 18.9
P/OCF 17.54
P/B 5.31
P/tB 11.8
EV/EBITDA 16.07
EPS(TTM)10.28
EY4.46%
EPS(NY)12.28
Fwd EY5.33%
FCF(TTM)12.2
FCFY5.29%
OCF(TTM)13.14
OCFY5.7%
SpS37.05
BVpS43.39
TBVpS19.54
PEG (NY)1.37
PEG (5Y)1.5
Graham Number100.18
Profitability
Industry RankSector Rank
ROA 17.47%
ROE 23.51%
ROCE 25.38%
ROIC 20.84%
ROICexc 25.9%
ROICexgc 63.96%
OM 34.11%
PM (TTM) 27.53%
GM 60.85%
FCFM 32.91%
ROA(3y)15.1%
ROA(5y)14.12%
ROE(3y)22.06%
ROE(5y)21.17%
ROIC(3y)18.06%
ROIC(5y)18.51%
ROICexc(3y)19.85%
ROICexc(5y)20.16%
ROICexgc(3y)47.68%
ROICexgc(5y)50.03%
ROCE(3y)22%
ROCE(5y)22.55%
ROICexgc growth 3Y8.61%
ROICexgc growth 5Y0.25%
ROICexc growth 3Y5.42%
ROICexc growth 5Y4.3%
OM growth 3Y5.43%
OM growth 5Y3.67%
PM growth 3Y7.71%
PM growth 5Y5.3%
GM growth 3Y1.6%
GM growth 5Y0.42%
F-Score6
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.37
Debt/EBITDA 0.2
Cap/Depr 67.31%
Cap/Sales 2.55%
Interest Coverage 53.22
Cash Conversion 93.57%
Profit Quality 119.57%
Current Ratio 3.06
Quick Ratio 2.32
Altman-Z 12.05
F-Score6
WACC10.01%
ROIC/WACC2.08
Cap/Depr(3y)65.59%
Cap/Depr(5y)70.36%
Cap/Sales(3y)2.53%
Cap/Sales(5y)3.12%
Profit Quality(3y)102.06%
Profit Quality(5y)92.37%
High Growth Momentum
Growth
EPS 1Y (TTM)16.29%
EPS 3Y18.15%
EPS 5Y14.94%
EPS Q2Q%15.64%
EPS Next Y16.4%
EPS Next 2Y13.39%
EPS Next 3Y11.65%
EPS Next 5Y10.77%
Revenue 1Y (TTM)9.57%
Revenue growth 3Y12.88%
Revenue growth 5Y11.72%
Sales Q2Q%10.98%
Revenue Next Year10.03%
Revenue Next 2Y8.69%
Revenue Next 3Y7.93%
Revenue Next 5Y8.4%
EBIT growth 1Y18%
EBIT growth 3Y19.01%
EBIT growth 5Y15.82%
EBIT Next Year26.45%
EBIT Next 3Y13.99%
EBIT Next 5Y11.01%
FCF growth 1Y88.25%
FCF growth 3Y103.78%
FCF growth 5Y18.84%
OCF growth 1Y77.41%
OCF growth 3Y70.86%
OCF growth 5Y16.9%

RESMED INC / RMD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of RESMED INC (RMD) stock?

ChartMill assigns a fundamental rating of 8 / 10 to RMD.


Can you provide the valuation status for RESMED INC?

ChartMill assigns a valuation rating of 6 / 10 to RESMED INC (RMD). This can be considered as Fairly Valued.


What is the profitability of RMD stock?

RESMED INC (RMD) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for RMD stock?

The Price/Earnings (PE) ratio for RESMED INC (RMD) is 22.42 and the Price/Book (PB) ratio is 5.31.


What is the financial health of RESMED INC (RMD) stock?

The financial health rating of RESMED INC (RMD) is 8 / 10.